Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Gilberto Lopes

Thoracic Oncology · University of Miami

View

Dr. Jacob Sands

Thoracic Oncology · Dana-Farber Cancer Institute

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Miksad

GI Oncology · BMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MSDr. Misty Shields
    Leading Voice

    Dr. Misty Shields

    Medical Oncology · Thoracic Oncology
    Indiana University School of Medicine
    misty

    Research

    Top advances of the year: Small cell lung cancer

    2025

    Via Cancer

    Research

    Comprehensive Genomic Profiling of Rare Lung Tumors: Adenosquamous Carcinoma and Pulmonary Carcinosarcoma

    2025

    Via Journal of Thoracic Oncology

    Research

    Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity

    2025

    Via Journal of Thoracic Oncology

    Research

    Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024

    2025

    Via Cancer

    Research

    Management of Central Nervous System Progression With Dose-Escalated Lorlatinib in ALK-Positive NSCLC: A Report of 2 Cases and Literature Review

    2025

    Via Clinical Lung Cancer

    Research

    Tarlatamab-Induced Tumor Lysis Syndrome in Small Cell Carcinoma: Case Series

    2025

    Via Clinical Lung Cancer

    Research

    Adenocarcinoma Harboring EGFR-ROS1 Fusion Treated With Osimertinib: A Case Report

    2024

    Via JTO Clinical and Research Reports

    Research

    Refining neoadjuvant immunotherapy for resectable lung cancer

    2024

    Via Nature Medicine

    Research

    Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer

    2024

    Via International Journal of Radiation Oncology, Biology, Physics

    Research

    Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

    2024

    Via Cell Reports Medicine

    Research

    Defining the needle in a haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors

    2024

    Via Lung Cancer

    Research

    Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

    2022

    Via Current Treatment Options in Oncology

    Research

    Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer

    2022

    Via International Journal of Molecular Sciences

    Research

    Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib

    2021

    Via Journal of Thoracic Oncology

    Research

    Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress

    2021

    Via American Society of Clinical Oncology Educational Book